This study aims to evaluate the diagnostic efficacies of the oncogenic long noncoding RNA MALAT1 and the tumor suppressor CASC2 as potential biomarkers for HCC on top of HCV in comparison to routinely used biomarkers. The gene discussed is CASC2; the disease is hepatocellular carcinoma.